Answers are grounded in this paper and cite their sources.
Aim: Diabetic Retinopathy (DR) is the most common microvascular complication of Diabetes Mellitus (DM). This study was carried out to determine blood and aqueous humor tumstatin level in patients (DM + cataract, in patients (DR+cataract), and patients only having cataract. Methods: Blood and aqueous humor were collected from patients. Tumstatin measurement is performed by Enzyme-Linked Immunosorbent Assays in Biological Samples (ELISA). Results: Blood and aqueous humor tumstatin were significantly raised in patients (diabetes mellitus + cataract) and in patients (diabetic retinopathy+cataract) as compared to patients only having cataract (their p values were less than 0.05). Aqueous humor tumstatin were higher than blood tumstatin having p values, 0.001. Conclusion: Taken together, these results demonstrate that diabetic retinopathy is associated with high levels of tumstatin and this peptide might be a novel potential therapeutic agent in diabetic retinopathy in the future.
No takes yet. Share an insight, caveat, or question.
Oruç et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: